- You can view the full Pfizer Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Merck & Co may face financial penalties from U.K. regulators after the Competition & Markets Authority released provisional findings of a drug pricing investigation into the American drugmaker.
Merck KGaA posted slightly stronger-than-expected first quarter earnings Thursday and nudged its full-year profit guidance higher after a key drug approval in the United States.
TheStreet's Jim Cramer weighs in on Home Depot, TJX Companies, Ford, Apple, Pfizer, Nike, Target and Alibaba.